Cargando…

The Causal Impact of the Gut Microbiota on Respiratory Tuberculosis Susceptibility

INTRODUCTION: Recent cross-sectional research has demonstrated a substantial link between tuberculosis (TB) and gut microbiota. Nevertheless, the causal impact of the gut microbiota on TB susceptibility in humans remains unknown. METHODS: The Mendelian randomization (MR) method was utilized for inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Jiayu, He, Jian-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651823/
https://www.ncbi.nlm.nih.gov/pubmed/37815754
http://dx.doi.org/10.1007/s40121-023-00880-4
Descripción
Sumario:INTRODUCTION: Recent cross-sectional research has demonstrated a substantial link between tuberculosis (TB) and gut microbiota. Nevertheless, the causal impact of the gut microbiota on TB susceptibility in humans remains unknown. METHODS: The Mendelian randomization (MR) method was utilized for investigating the causality between them. The main method used for MR analysis was the inverse variance weighted (IVW) test, with the MR-Egger, weighted median, weighted mode, and simple median methods serving as supplements. And several sensitivity tests were carried out to validate the MR findings. RESULTS: The IVW outcomes suggested that three bacterial traits exhibited associations with susceptibility to respiratory TB after Bonferroni correction, namely Lachnospiraceae UCG010 (odds ratio [OR] 1.73, 95% confidence interval [CI] 1.17–2.55, P = 0.005), Eubacterium (brachy group) (OR 1.33, 95% CI 1.07–1.65, P = 0.009), and Ruminococcaceae UCG005 (OR 0.71, 95% CI 0.52–0.98, P = 0.034). Sensitivity analyses demonstrated that horizontal pleiotropy and heterogeneity were absent, thereby guaranteeing the reliability of the results. CONCLUSION: This research sheds light on the causal impact of gut microbiota on respiratory tuberculosis susceptibility, improving our knowledge of therapeutic strategies for managing TB. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40121-023-00880-4.